Scribd Logo
Unggah

Selamat datang di Scribd!

  • Jan 09

    Diunggah oleh

    Q.net
    18 tayangan1 halaman
    The sales and stock report for January 2009 shows beginning stock levels, sales, expired stock removed from stock, output from production, input added to stock, and ending stock levels for various drugs. Key drugs like novonorm 0.5mg and 1mg had high sales volumes while maintaining good ending stock levels. Vagifem stock was reduced due to expired drugs being removed from stock. Production of novomix and consumption through sales was roughly equal, maintaining a similar ending stock level.

    Deskripsi Asli:

    Judul Asli

    jan.09

    Hak Cipta

    © Attribution Non-Commercial (BY-NC)

    Format Tersedia

    XLS atau baca online dari Scribd

    Apakah menurut Anda dokumen ini bermanfaat?

    Apakah konten ini tidak pantas?

    Laporkan Dokumen Ini
    The sales and stock report for January 2009 shows beginning stock levels, sales, expired stock removed from stock, output from production, input added to stock, and ending stock levels for various drugs. Key drugs like novonorm 0.5mg and 1mg had high sales volumes while maintaining good ending stock levels. Vagifem stock was reduced due to expired drugs being removed from stock. Production of novomix and consumption through sales was roughly equal, maintaining a similar ending stock level.

    Hak Cipta:

    Attribution Non-Commercial (BY-NC)
    Unduh sebagai XLS atau baca online dari Scribd
    Tandai sebagai konten tidak pantas
    18 tayangan1 halaman

    Jan 09

    Diunggah oleh

    Q.net
    The sales and stock report for January 2009 shows beginning stock levels, sales, expired stock removed from stock, output from production, input added to stock, and ending stock levels for various drugs. Key drugs like novonorm 0.5mg and 1mg had high sales volumes while maintaining good ending stock levels. Vagifem stock was reduced due to expired drugs being removed from stock. Production of novomix and consumption through sales was roughly equal, maintaining a similar ending stock level.

    Hak Cipta:

    Attribution Non-Commercial (BY-NC)
    Unduh sebagai XLS atau baca online dari Scribd
    Tandai sebagai konten tidak pantas
    dari 1

    The sale & stock's report for jan.

    2009:
    item beg. Of jan sales sam.lo.fr.ex. output input end stock
    novonorm 0.5mg 951 620 620 331

    novonorm 1mg 1358 130 130 1228

    novonorm 2mg 1808 0 1808


    0
    trisequens 1208 1200 1 1201 7

    vagifem 1983 88 133 221 1762


    expired 8-08
    mixtard 1586 49 49 1537

    novo fine 8 7 7 1

    novo pen 125 4 4 121

    novomix 547.8 113 18 131 69 485.8

    norditropin 10mg 86 0 86
    0 0
    utrogestan 100mg 11290 4270 26 4296 6994
    0 0
    cebedex 3742 100 100 3642

    cebemyxine 1980 0 1980


    0 0
    kolestor 20mg 0 150 150 150 0

    sinopryl 5mg 2090 0 2090

    sinopryl 10mg 1551 100 100 1451

    amlodis 5mg 522 150 150 372

    amlodis 10mg 1617 50 50 1567


    0 0
    omedica soft 0 143 0.03 143.03 151 7.98
    fujica 0 48.98 0.03 49 49 0
    omedica AID 0 3 3 3 0
    omedica yaki 36.45 4 0.45 4.45 19 51
    omedica ipek 5*5 26.89 2 0.01 2.01 25 49.88
    omedica ipek 2.5*5 0 2 0.09 2.09 25 22.91

    Anda mungkin juga menyukai